Skip to content
lifestyle.usfeatures.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Deerfield Group
Built for This: Deerfield Group Expands Leadership to Advance Next Phase of Growth, Harnessing Innovation, Technology Anchored in Human Expertise
September 15, 2026
DEERFIELD GROUP ANNOUNCES STRATEGIC INVESTMENT FROM MARTIS CAPITAL TO FUEL NEXT PHASE OF GROWTH
June 30, 2026
Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology Annual Meeting
May 24, 2026
/C O R R E C T I O N — InMed Pharmaceuticals/
May 24, 2026
Petrichor Names Diagnostics Industry Leader Don Hardison as Operating Partner
May 23, 2026
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies
May 23, 2026
Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial
May 23, 2026
HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy
April 29, 2026
Deerfield Group Launches Prismatiq™, an Intuitive Field Enablement Platform Purpose-Built for Life Sciences
April 22, 2026
Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
April 17, 2026
1
2
Next Page
→